Nivolumab/osimertinibInterstitial lung disease: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2017年 / 1666卷 / 1期

关键词：

D O I：

10.1007/s40278-017-35067-4

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：225 / 225

相关论文

共 50 条

[21] Nivolumab/osimertinibInterstitial lung disease and interstitial pneumonia: 2 case reports
Reactions Weekly, 2016, 1619 (1) : 141 - 141
[22] Nivolumab/osimertinibInterstitial lung diseases: 3 case reports
Reactions Weekly, 2019, 1753 (1) : 262 - 262
[23] OsimertinibInterstitial lung disease manifesting as eosinophilic pneumonia: case report
Reactions Weekly, 2017, 1682 (1) : 248 - 248
[24] Erlotinib/osimertinibInterstitial lung disease and acquired resistance in lung adenocarcinoma: case report
Reactions Weekly, 2019, 1736 (1) : 104 - 104
[25] Gefitinib/osimertinibInterstitial lung diseases: case report
Reactions Weekly, 2021, 1839 (1) : 146 - 146
[26] OsimertinibInterstitial lung disease: 2 case reports
Reactions Weekly, 2017, 1659 (1) : 228 - 228
[27] OsimertinibInterstitial lung disease: 15 case reports
Reactions Weekly, 2023, 1946 (1) : 447 - 447
[28] OsimertinibInterstitial lung disease: 6 case reports
Reactions Weekly, 2020, 1832 (1) : 233 - 233
[29] OsimertinibInterstitial lung disease: 2 case reports
Reactions Weekly, 2017, 1679 (1) : 147 - 147
[30] OsimertinibInterstitial lung disease
Reactions Weekly, 2023, 1986 (1) : 349 - 349

← 1 2 3 4 5 →